H
The startup develops drugs utilizing a protein that prevents tissue degeneration, targeting the biological mechanisms of aging. Their treatments aim to reduce skin and hair aging while effectively managing osteoarthritis symptoms.
Updated 18 months ago
Funding
$8.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
QV
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops drugs utilizing a protein that prevents tissue degeneration, targeting the biological mechanisms of aging. Their treatments aim to reduce skin and hair aging while effectively managing osteoarthritis symptoms.